Viveo Completes R$1.2 Billion Follow-On Offering of Common Shares
08.07.23
This is only gets display when printing
Simpson Thacher represented CM Hospitalar S.A. (“Viveo”) in connection with the follow-on offering of R$1.2 billion aggregate principal amount of its common shares on the São Paulo Stock Exchange (B3). The offering consisted of a primary offering of 36,697,248 common shares and a secondary offering of 21,000,000 common shares, at a price per common share of R$21.21.
The common shares were offered to qualified institutional buyers in the United States under Rule 144A and to non-U.S. persons in reliance on Regulation S. A concurrent offering was conducted in Brazil in compliance with CVM Resolution No. 160 and CVM Resolution No. 30. The common shares are listed on the São Paulo Stock Exchange (B3) under the ticker symbol “VVEO3.”
Viveo is an one-stop-shop ecosystem of healthcare products and services offering solutions ranging from product manufacturing to delivery to customers. Viveo offers a range of services to facilitate the management of supplies and medicines, serving hospitals, clinics, laboratories, pharmacies and direct patient care.
The Simpson Thacher team for the transaction included Grenfel S. Calheiros, Paulo F. Cardoso, Isabel de Carvalho and Susan Uquillas (Capital Markets - São Paulo); and Jonathan Cantor and Scott Grundei (Tax).